Invesco Ltd. Durect Corp Transaction History

Invesco Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.64 $29,005 - $48,851	-76,330 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.55 - $0.98 $969 - $1,727	-1,763 Reduced 2.26%	76,330 $51,000
Q4 2021 Feb 14, 2022	SELL	$0.9 - $1.31 $17,813 - $25,928	-19,793 Reduced 20.22%	78,093 $77,000
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.61 $24,210 - $32,214	20,009 Added 25.69%	97,886 $125,000
Q2 2021 Aug 17, 2021	SELL	$1.6 - $2.02 $70,636 - $89,178	-44,148 Reduced 36.18%	77,877 $127,000
Q1 2021 May 17, 2021	SELL	$1.86 - $2.87 $20 - $31	-11 Reduced 0.01%	122,025 $241,000
Q4 2020 Feb 16, 2021	SELL	$1.65 - $2.43 $18,313 - $26,970	-11,099 Reduced 8.34%	122,036 $253,000
Q3 2020 Nov 16, 2020	SELL	$1.6 - $2.35 $29,308 - $43,047	-18,318 Reduced 12.09%	133,135 $227,000
Q2 2020 Aug 14, 2020	BUY	$1.33 - $2.76 $201,432 - $418,010	151,453 New	151,453 $352,000
Q1 2019 May 15, 2019	SELL	$0.51 - $0.82 $22,690 - $36,483	-44,492 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.48 - $1.1 $21,356 - $48,941	44,492 New	44,492 $21,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $178M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.